8:00 - 19:00

Working hours MON. - FRI.

Pfizer Profit, CVS Outlook, Conoco: 3 Things to Watch By Investing.com

By Liz Moyer Investing.com -- Stocks rose Monday, except the tech-heavy NASDAQ Composite, as another 130 companies prepared to release quarterly results this week. The big economic data for the week comes at the end: the jobs report for April, which many are expecting will show a continued rebound in the labor market. Upbeat earnings last week are setting the market’s tone, today's drop in the Nasdaq notwithstanding. Tech giants Apple Inc (NASDAQ:AAPL), Facebook Inc (NASDAQ:FB), and Google’s Alphabet (NASDAQ:GOOGL) Inc Class C (NASDAQ:GOOG)smashed expectations. But for some companies, like ...

Continue reading

Dow Racks Up Gains as Cyclicals Run Higher on Reopening Momentum By Investing.com

By Yasin Ebrahim Investing.com – The Dow closed higher Monday as signs of a faster reopening of the economy pushed cyclicals corners of the market including energy and materials higher.   The Dow Jones Industrial Average ended up 0.70%, or 239 points, the S&P 500 was up 0.27%, and the Nasdaq Composite was down 0.44%. Energy led the broader market higher, underpinned by rising oil prices as investors renewed bets on a recovery in global demand despite Covid-19 cases in India that continue to mount. "Support from the economy’s reopening is being reinforced by aggressive fiscal and...

Continue reading

Buffett’s Probable Successor Helps Shares Hit Record By Investing.com

By Christiana Sciaudone Investing.com -- Berkshire Hathaway B (NYSE:BRKb) hit a record after Warren Buffett kinda named his replacement this weekend.   Vice Chairman Greg Abel, who runs the company's non-insurance operations, will likely take over for the billionaire after CEO and Chairman Buffett told CNBC that, "the directors are in agreement that if something were to happen to me tonight, it would be Greg who’d take over tomorrow morning." There has long been speculation over who will be the next person to lead the legendary investor's company. Berkshire Hathaway (NYSE:BRKa) is, of...

Continue reading

Meme Stock Ocugen Jumps as Vaccine Shows Efficacy Versus Variants By Investing.com

By Christiana Sciaudone Investing.com -- Meme stock Ocugen (NASDAQ:OCGN) soared 20% as it may have discovered a vaccine against the Brazil Covid-19 variant. Scientists at Indian Council of Medical Research (ICMR)-National Institute of Virology previously found that Covaxin is effective against the U.K. variant and the Indian double mutant.   Shares of Ocugen shot up in January alongside Gamestop and AMC Entertainment (NYSE:AMC) as retail traders tried to take on the man by buying up stocks that had been shorted, meaning institutional investors expected them to tank at some point. Shares also rose after an April 21...

Continue reading

Canada shares higher at close of trade; S&P/TSX Composite up 0.68% By Investing.com

Investing.com – Canada equities were higher at the close on Monday, as gains in the Materials, Energy and REITs sectors propelled shares higher. At the close in Toronto, the S&P/TSX Composite added 0.68%. The biggest gainers of the session on the S&P/TSX Composite were NexGen Energy Ltd. (TSX:NXE), which rose 15.30% or 0.710 points to trade at 5.350 at the close. Silvercorp Metals Inc (TSX:SVM) added 12.54% or 0.81 points to end at 7.27 and Endeavour Silver Corp. (TSX:EDR) was up 10.96% or 0.710 points to 7.190 in late trade....

Continue reading

Estee Lauder Appears to Be Missing The Reopening Boom By Investing.com

By Christiana Sciaudone Investing.com -- Estee Lauder (NYSE:EL) tumbled more than 8% as the beauty products maker appears to be missing out on the reopening trade. Sales for the third fiscal quarter of $3.87 billion missed the average forecast of $3.94 billion. That said, profit of $1.59 was far better than expected ($1.32), according to data compiled by Investing.com. Fiscal full year sales are expected to increase up to 12% versus the prior year, the company said in a statement. Estee Lauder had hit a record prior to today's news, though shares...

Continue reading

Dow Rallies on Bullish Bets in Energy, Materials By Investing.com

By Yasin Ebrahim Investing.com – The S&P 500 climbed Monday, led by energy and materials on signs of an ongoing recovery as the reopening of the economy continues to advance. The Dow Jones Industrial Average rose 0.82, or 279 points, the S&P 500 was up 0.35%, and the Nasdaq Composite was down 0.47%. Energy led the broader market higher, underpinned by rising oil prices as investors renewed bet on a recovery in global demand despite the threat of a slower recovery as Covid-19 cases in India continue to mount. "Support from the economy’s reopening is being...

Continue reading

White House Backs Pfizer’s Move to Begin U.S. Vaccine Exports By Bloomberg

(Bloomberg) -- The Biden administration will support Pfizer Inc (NYSE:PFE).’s move to begin exporting U.S.-made doses of its coronavirus vaccine, as the White House starts to unleash U.S. production for shot-starved nations abroad. “We are glad to see that they are working with other countries to help them meet their supply needs,” Jeff Zients, President Joe Biden’s Covid-19 response coordinator, told Bloomberg News in a statement. He said the company is ahead of schedule in its commitments to supply the U.S. The governments of Mexico and Canada said last week that...

Continue reading

IBM Rises on Street-High Price Target By Investing.com

By Christiana Sciaudone Investing.com -- IBM (NYSE:IBM) rose 1.8% after getting a Street-high price target on expected growth ahead. BofA Securities set the price target for IBM at $175 from $153, forecasting sustaining growth after it spins off its infrastructure services business later this year, StreetInsider reported.  Analyst Wamsi Mohan reiterated a buy rating on the company after hosting an investor call with Chief Executive Officer Arvind Krishna. "IBM is seeing the majority of clients adopting a hybrid cloud approach given regulations, latency concerns and data sovereignty," Mohan said. "Red Hat enables...

Continue reading

BioNTech Soars to Record as Vaccine Success Spurs on Biotechs By Bloomberg

(Bloomberg) -- BioNTech SE (NASDAQ:BNTX), the vaccine maker partnered with Pfizer Inc. (NYSE:PFE) on its Covid-19 shot, rose as much as 10% on Monday as the stock rallied past $200 a share at the open, breaking yet another record after closing at new highs four out of five days last week. The German company was among the top gainers as the biotech sector regained lost footing and optimism about economies reopening bolstered stocks. Shots from Pfizer and BioNTech as well as Moderna (NASDAQ:MRNA) Inc. have helped the U.S....

Continue reading
en_GBEnglish